Elaine Murray

Pregnancy outcomes after maternal exposure to rituximab

Eliza F. Chakravarty, Elaine Murray, Ariella Kelman et al. · Blood · 2010 · 577 citations · Full text

Medicine, Immunology, Obstetrics +14

A First-in-Human Phase I Study to Evaluate the ERK1/2 Inhibitor GDC-0994 in Patients with Advanced Solid Tumors

Andréa Varga, Jean‐Charles Soria, Antoine Hollebecque et al. · Clinical Cancer Research · 2019 · 86 citations

Medicine, Oncology, Pharmacology +15

First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL

John C. Byrd, Stephen D. Smith, Nina D. Wagner‐Johnston et al. · Oncotarget · 2018 · 83 citations · Full text

Medicine, Hematology, Oncology +17

Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumors

Antoîne Italiano, Jeffrey R. Infante, Geoffrey I. Shapiro et al. · Annals of Oncology · 2018 · 78 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I Study of GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination with Gemcitabine in Patients with Refractory Solid Tumors

Jeffrey R. Infante, Antoine Hollebecque, Sophie Postel‐Vinay et al. · Clinical Cancer Research · 2016 · 70 citations

Medicine, Oncology, Pharmacology +17